Literature DB >> 30735082

Polymicrobial Bacteremia Involving Klebsiella pneumoniae in Patients with Complicated Intra-Abdominal Infections: Frequency, Co-Pathogens, Risk Factors, and Clinical Outcomes.

Qinjie Liu1, Jie Wu1, Zhiwei Wang2, Xiuwen Wu1, Gefei Wang1, Jianan Ren1,2.   

Abstract

Background: Klebsiella pneumoniae has gained notoriety because of its high antibiotic resistance and mortality. We compared the clinical features and outcomes of polymicrobial bacteremia involving K. pneumoniae (PBKP). Patients and
Methods: A retrospective observational study of patients with polymicrobial and monomicrobial bacteremia involving K. pneumoniae from January 2012 to December 2016 was performed. The expression of resistance and virulence genes of 27 strains was also compared by polymerase chain reaction (PCR).
Results: Among the polymicrobial group, the most common accompanying micro-organism was Escherichia coli. No differences in the expression of resistance and virulence genes was found among the 27 strains collected from the group. The analysis of the outcomes revealed that the patients with PBKP were more likely to have recurrent blood stream infections (p = 0.038), longer intensive care unit (ICU) lengths of stay (p = 0.043), and a higher total hospitalization cost (p = 0.045). However, no substantial differences in mortality were found between the two groups. The multivariable analysis revealed that a longer hospital stay prior to the onset of bacteremia (>20 days) was an independent risk factor for PBKP (p = 0.034), and the Sequential Organ Failure Assessment (SOFA) score upon onset of infection (p = 0.013), the adequacy of source control (p < 0.001), and iron supplementation (p = 0.003) were identified as independent predictors of mortality in patients with KP bacteremia. Conclusions: The development of septic shock and the concomitant use of iron supplementation are associated with higher mortality in patients with KP bacteremia, and PBKP did not increase the mortality of these patients, possibly because of the ability of K. pneumoniae to obscure the effects of other bacteria. Thus, adequate source control is more important than high-dose antibiotic therapy and is linked to higher survival.

Entities:  

Keywords:  bacteremia; bacteremia-related mortality; complicated intra-abdominal infections; iron supplementation; polymicrobial

Mesh:

Substances:

Year:  2019        PMID: 30735082     DOI: 10.1089/sur.2018.207

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  5 in total

Review 1.  Molecular Methodologies for Improved Polymicrobial Sepsis Diagnosis.

Authors:  Mariam Doualeh; Matthew Payne; Edward Litton; Edward Raby; Andrew Currie
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?

Authors:  Yung-Chih Wang; Wen-Wei Ku; Ya-Sung Yang; Chih-Chun Kao; Fang-Yu Kang; Shu-Chen Kuo; Chun-Hsiang Chiu; Te-Li Chen; Fu-Der Wang; And Yi-Tzu Lee
Journal:  J Clin Med       Date:  2020-01-06       Impact factor: 4.241

3.  Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter baumannii Bloodstream Infections.

Authors:  Zhenhua Qian; Shufang Zhang; Na Li; Weixing Ma; Kai Zhang; Feizhen Song; Cheng Zheng; Li Zhong; Yesong Wang; Jiachang Cai; Hongwei Zhou; Wei Cui; Gensheng Zhang
Journal:  Biomed Res Int       Date:  2022-02-27       Impact factor: 3.411

4.  The interaction between STING and NCOA4 exacerbates lethal sepsis by orchestrating ferroptosis and inflammatory responses in macrophages.

Authors:  Jie Wu; Qinjie Liu; Xufei Zhang; Miaomiao Tan; Xuanheng Li; Peizhao Liu; Lei Wu; Fan Jiao; Zhaoyu Lin; Xiuwen Wu; Xin Wang; Yun Zhao; Jianan Ren
Journal:  Cell Death Dis       Date:  2022-07-28       Impact factor: 9.685

5.  Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella pneumoniae Bloodstream Infections.

Authors:  Feizhen Song; Kai Zhang; Jianjiang Huang; Zhenhua Qian; Hongwei Zhou; Jiachang Cai; Cheng Zheng; Feifei Zhou; Wei Cui; Gensheng Zhang
Journal:  Biomed Res Int       Date:  2021-06-19       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.